regulatory
confidence high
sentiment negative
materiality 0.60
Equillium, Inc. (EQ): Nasdaq/NYSE listing notice — Equillium receives Nasdaq bid price deficiency notice; has until Oct 2, 2023 to regain compliance
Equillium, Inc.
- Nasdaq notified Equillium on April 5, 2023 that its common stock bid price closed below $1.00 for 30 consecutive business days.
- Company has 180 calendar days, until October 2, 2023, to regain compliance by closing at $1.00 or more for 10 consecutive business days.
- If not compliant by Oct 2, Equillium may transfer to Nasdaq Capital Market for an additional 180-day cure period, subject to meeting other listing standards.
- Company is considering available options, including a reverse stock split, to cure the deficiency.
- Non-compliance has no immediate effect on listing or trading of EQ common stock on Nasdaq Global Market.